Glucon logo — Experience seamless, precise, and real-time glucose monitori...

Glucon

Experience seamless, precise, and real-time glucose monitoring with top-notch Photoacoustic technology in a compact, wearable device.

Founded 2000 Series D Total: $25.63M

General Information

Company Name Glucon
Founded Year 2000
Funding Stage Series D
Social

Get notified when Glucon moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Glucon

Glucon is a development stage company with a focus on creating glucose monitoring devices for the diabetes market. The company's slogan "Experience seamless, precise, and real-time glucose monitoring with top-notch Photoacoustic technology in a compact, wearable device" encapsulates its mission. Utilizing a novel Photoacoustic technology, which is protected by several granted and pending patents, the devices are designed to be small and conveniently wearable, offering continuous, accurate, and real-time glucose monitoring for both clinical and personal use. Glucon has demonstrated the superior performance of Photoacoustics compared to optics alone, providing direct blood glucose measurements from inside blood vessels, enhancing both the specificity and sensitivity of glucose measurement. The company's desktop prototype device is currently undergoing extensive clinical trials. In terms of funding, Glucon received its last investment in the form of a Series D investment on 22 January 2007. The investors involved in this round included 3i Group, Giza Venture Capital, Quest Capital, Sequel Venture Partners, Covera Ventures, Ascend Technology Ventures, and MKI. With its innovative approach to glucose monitoring and ongoing clinical trials, Glucon presents an intriguing investment opportunity in the healthcare technology space.

Taxonomy: glucose monitoring, Photoacoustic technology, diabetes market, wearable devices, clinical trials, optical and sound-based methods, patents, real-time monitoring, specificity, sensitivity, blood glucose measurements, novel technology, compact device, precision, continuous monitoring

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series D •••••• 7
Investor Investor Investor Investor Investor Investor
•••• ••••
22 Jan 2007
Series C •••••• 1
Investor
10 Feb 2005
Series A •••••• 2
Investor
•••• ••••
07 Jan 2004

Glucon Alternatives & Competitors

Glucon vs

Making life with diabetes easier

Debt Financing
65 employees
Biotechnology, Health Care
Glucon vs
AgaMatrix
AgaMatrix United States

We design, develop, and manufacture world-class products for diabetes care.

Debt Financing
89 employees
Health Care, Manufacturing
Glucon vs

Developing a non-invasive technology that continuously measures blood glucose levels using RF waves.

Series C
Health Care, Medical Devices

FAQ About Glucon

Experience seamless, precise, and real-time glucose monitoring with top-notch Photoacoustic technology in a compact, wearable device.
Glucon was founded in 2000.
Glucon has completed 3 funding rounds, raising a total of $25.63M. The latest funding stage is Series D.
Top alternatives and competitors to Glucon include Intuity Medical, Inc., AgaMatrix, GWave, OptiScan Biomedical Corporation, GraphWear Technologies Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Glucon and Intuity Medical, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Glucon and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy